|
Number of cycles (median - range)
|
5 [1 - 21]
|
|
Treatment response (n - %)
|
|
CR
|
1/43 – 2.3%
|
|
PR
|
7/43 - 16.3%
|
|
SD
|
17/43 - 39.5%
|
|
PD
|
18/43 - 41.9%
|
|
Clinical benefit
|
25/43 - 58.1%
|
|
ORR
|
8/43 - 18.6%
|
|
TTP (median - range)
|
5 [2 - 21] months
|
|
OS (median - range)
|
9 [3 - 29] months
|
|
Percentage of alive patients (n - %)
|
|
year 1
|
16/43 - 37.2%
|
|
year 2
|
4/43 - 9.3%
|
- CR = complete response; PR = partial response; SD = stable disease; PD = disease progression; ORR = overall response rate; TTP = time to progression; OS = overall survival.
